Racura Oncology LtdASX: RAC

Racure Oncology Techknow Invest Presentation

Jul 28, 2026 at 7:12 PM EDT · Issued by Racura Oncology Ltd via ASX

Filed with ASX · Jul 28, 2026 at 7:12 PM EDT

On 6ix: 6ix.com/news/racure-oncology-techknow-invest-presentation

Racura Oncology Ltd | ABN 61 149 318 749 | L36 1 Macquarie Place Sydney NSW 2000 Australia +61 2 8051 3043 | [email protected] | www.racuraoncology.com 1 ASX Announcement Racura Oncology to Present at TechKnow Invest Conference 29 July 2026 Racura Oncology Limited...

View Attachment

6ix hasn’t read this filing yet.

Racura Oncology Ltd on 6ix

In the deck

Racura Oncology — TechKnow Invest Conference 202616 slidesJul 29, 2026

Earlier from Racura Oncology

June 2026 Quarterly Activities Report and Appendix 4CJul 27
Bellberry Ethics Approval Activates New HARNESS Trial SitesJul 2
Racura Oncology Doses First Patient in Phase 1 HARNESS-1 Trial of RC220 in EGFR-Mutant Non-Small Cell Lung CancerJun 25
Racura Treats First Patient in HARNESS-1 Lung Cancer TrialJun 24
Racura raised $34.3m to Advance Three Oncology TrialsJun 15

Later from Racura Oncology

First HARNESS-1 Patient Safely Treated with RC220Jul 28
Appendix 4E & Annual ReportAug 25
Appendix 4GAug 25
Corporate Governance StatementAug 25
CPACS Trial Opens for RC220 Patient Enrolment in KoreaAug 31

All Racura Oncology news releases

Follow Racura Oncology into a list and get an email when it puts out news.

Follow Racura Oncology